SYNC-T, an investigational therapy that combines a device-induced vaccination at the tumor site with intratumoral infusion of a multitarget biologic drug led to numerous clinical responses in patients with metastatic castrate-resistant ...
Apr 8, 2024
0
0
Integrating magnetic resonance imaging (MRI) into prostate cancer (PCa) screening is associated with a reduction in unnecessary biopsies and overdiagnosis of insignificant disease, according to a review published online April ...
Apr 8, 2024
0
1
The largest study to date investigating a single invitation to a PSA blood test to screen for prostate cancer has found it had a small impact on reducing deaths, but also led to overdiagnosis and missed early detection of ...
Apr 6, 2024
0
122
A simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown.
Apr 5, 2024
0
0
Annual prostate cancer cases worldwide are projected to double by the year 2040, and annual deaths are projected to increase by 85% to almost 700,000 over the same timeframe—mainly among men in low- and middle-income countries. ...
Apr 4, 2024
1
106
Patients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a study published online March 19 in the Journal of the American Academy of Dermatology.
Apr 4, 2024
0
0
The recent revelations about the Princess of Wales's cancer diagnosis highlight a crucial aspect of cancer detection—the disease's sometimes silent nature.
Apr 2, 2024
0
0
Cancer rates, especially among young people, are on the rise. There's expected to be 2 million new cancer diagnoses in the United States in 2024.
Mar 30, 2024
0
16
MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests
Mar 29, 2024
0
2
Ever since Anthony Bridges found out he had prostate cancer six years ago, he hasn't stopped talking about it. He told his Facebook friends immediately.
Mar 28, 2024
0
0
